• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.

作者信息

Vassilakopoulos Theodoros P, Kravvariti Evrydiki, Panitsas Fotios, Angelopoulou Maria K, Liaskas Athanasios, Kontopidou Flora N, Yiakoumis Xanthoula, Variami Eleni, Dimopoulou Maria N, Siakantaris Marina P, Asimakopoulos John V, Arapaki Maria, Dimou Maria, Diamantopoulos Panagiotis, Sachanas Sotirios, Chatzidimitriou Chrysovalantou, Belia Marina, Konstantinou Elianna, Boutsikas George, Petevi Kyriaki, Kanellopoulos Alexandros, Kokoris Styliani, Kyrtsonis Marie-Christine, Viniou Nora-Athina, Lakiotaki Eleftheria, Tsourouflis Gerasimos, Korkolopoulou Penelope, Konstantopoulos Kostas, Panayiotidis Panayiotis, Pangalis Gerassimos A

机构信息

Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.

First Department of Propaedeutic Internal Medicine, Joint Rheumatology Academic Program, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.

出版信息

Blood Cancer J. 2022 Jul 5;12(7):102. doi: 10.1038/s41408-022-00674-w.

DOI:10.1038/s41408-022-00674-w
PMID:35790712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9256621/
Abstract
摘要

相似文献

1
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.接受化疗联合或不联合放疗治疗的霍奇金淋巴瘤的极晚期复发：线性模式及独特的预后因素
Blood Cancer J. 2022 Jul 5;12(7):102. doi: 10.1038/s41408-022-00674-w.
2
Treatment of lymphocyte-predominant Hodgkin lymphoma.淋巴细胞为主型霍奇金淋巴瘤的治疗
Ann Oncol. 2008 Jun;19 Suppl 4:iv45-6. doi: 10.1093/annonc/mdn194.
3
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].[150例早期霍奇金淋巴瘤的综合治疗]
Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):630-4.
4
Central nervous system relapse in Hodgkin lymphoma: Successful treatment without radiotherapy.霍奇金淋巴瘤中枢神经系统复发：无需放疗的成功治疗
Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26277. Epub 2016 Oct 12.
5
Management of Relapsed and Refractory Hodgkin Lymphoma in 2018.
JAMA Oncol. 2018 Aug 1;4(8):1120-1121. doi: 10.1001/jamaoncol.2018.1767.
6
Combination chemoradiotherapy in early Hodgkin lymphoma.早期霍奇金淋巴瘤的联合化放疗。
Hematol Oncol Clin North Am. 2014 Feb;28(1):33-47. doi: 10.1016/j.hoc.2013.10.010.
7
Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.青年期霍奇金淋巴瘤患者存在复发风险：霍奇金淋巴瘤迟发复发的综合分析。
J Cancer Res Clin Oncol. 2018 May;144(5):935-943. doi: 10.1007/s00432-018-2613-9. Epub 2018 Feb 21.
8
Hodgkin lymphoma.霍奇金淋巴瘤
J Natl Compr Canc Netw. 2011 Sep 1;9(9):1020-58. doi: 10.6004/jnccn.2011.0086.
9
Unusual presentation of classic Hodgkin lymphoma.
Blood. 2019 Jan 31;133(5):502. doi: 10.1182/blood-2018-10-878058.
10
Chemotherapy only in early stage Hodgkin lymphoma: more relapses but the same survival--what to do?
Curr Hematol Malig Rep. 2014 Sep;9(3):217-21. doi: 10.1007/s11899-014-0214-5.

引用本文的文献

1
Treatment Classification by Intent in Oncology-The Need for Meaningful Definitions: Curative, Palliative and Potentially Life-Prolonging.肿瘤学中按治疗意图进行的治疗分类——对有意义定义的需求：治愈性、姑息性和潜在延长生命性。
J Pers Med. 2024 Aug 31;14(9):932. doi: 10.3390/jpm14090932.
2
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: Long-term results of a prospective, multicenter study.HIV相关霍奇金淋巴瘤的分期适应性治疗：一项前瞻性多中心研究的长期结果
Hemasphere. 2024 Jul 3;8(7):e68. doi: 10.1002/hem3.68. eCollection 2024 Jul.
3
Harnessing multi-source data for individualized care in Hodgkin Lymphoma.

本文引用的文献

1
Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.青年期霍奇金淋巴瘤患者存在复发风险：霍奇金淋巴瘤迟发复发的综合分析。
J Cancer Res Clin Oncol. 2018 May;144(5):935-943. doi: 10.1007/s00432-018-2613-9. Epub 2018 Feb 21.
2
Late relapse of Hodgkin's lymphoma - is it different in clinical characteristics and outcome?霍奇金淋巴瘤的晚期复发——其临床特征和预后是否有所不同？
J BUON. 2017 Mar-Apr;22(2):481-486.
3
Prognostic factors in Hodgkin lymphoma.霍奇金淋巴瘤的预后因素
利用多源数据为霍奇金淋巴瘤患者提供个体化护理。
Blood Rev. 2024 May;65:101170. doi: 10.1016/j.blre.2024.101170. Epub 2024 Jan 14.
4
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma.将单克隆抗体纳入经典型霍奇金淋巴瘤的一线治疗。
Int J Mol Sci. 2023 Aug 24;24(17):13187. doi: 10.3390/ijms241713187.
5
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.相当一部分经典型霍奇金淋巴瘤的复发表现为与克隆无关的第二原发性淋巴瘤。
Blood Adv. 2023 Oct 10;7(19):5911-5924. doi: 10.1182/bloodadvances.2023010412.
Semin Hematol. 2016 Jul;53(3):155-64. doi: 10.1053/j.seminhematol.2016.05.003. Epub 2016 May 12.
4
Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia.不列颠哥伦比亚省无事件生存时间点评估经典霍奇金淋巴瘤的复发风险，并与普通人群的生存比较。
J Clin Oncol. 2016 Jul 20;34(21):2493-500. doi: 10.1200/JCO.2015.65.4194. Epub 2016 Jun 6.
5
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.本妥昔单抗维泊妥珠单抗作为自体造血干细胞移植后巩固治疗在有复发或进展风险的霍奇金淋巴瘤患者中的应用（AETHERA）：一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2015 May 9;385(9980):1853-62. doi: 10.1016/S0140-6736(15)60165-9. Epub 2015 Mar 19.
6
Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.霍奇金淋巴瘤患者极晚期复发的结局
Adv Hematol. 2011;2011:707542. doi: 10.1155/2011/707542. Epub 2010 Dec 29.
7
Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study.霍奇金淋巴瘤的晚期复发：一项临床和免疫组织化学研究。
Leuk Lymphoma. 2010 Sep;51(9):1686-91. doi: 10.3109/10428194.2010.500432.
8
Very late relapse of Hodgkin's disease: a report of five patients.霍奇金淋巴瘤的极晚期复发：5例患者报告
Am J Clin Oncol. 2001 Dec;24(6):576-8. doi: 10.1097/00000421-200112000-00009.
9
Favorable prognosis after late relapse of Hodgkin's disease.霍奇金淋巴瘤晚期复发后预后良好。
Cancer. 1998 Aug 1;83(3):560-5.
10
Late relapse after treatment for clinical stage I and II Hodgkin's disease.临床I期和II期霍奇金淋巴瘤治疗后的晚期复发。
Cancer. 1997 Apr 1;79(7):1422-7.